DAILY MARKET INSIGHTS

13-May-2020

Change Index points KSE 100 INDEX PERFORMANCE OVERVIEW PKR % Change Closing KSE 100 Index 90 33,693 Contributing shares Closing Price - Rs. . 2.09 2.15 33.98 99.10 Limited. 1.81 2.03 26.73 91.04 Sui Northern Gas Pipe Line Ltd. (3.95) (6.90) (24.99) 53.30

KSE 100 INDEX VOLUMES

Today 143 5 days average 114 136 14 days average Millions

Source: https://formerdps.psx.com.pk/ & Calculations of Kifayah Investment Management Limited

Top most buyer Top most seller PORTFOLIO INVESTMENT SUMMARY Insurance Companies Foreign Corporates Amount (Net) 471,390,801 (697,685,595) Buying / Selling sector wise composition Cement 49.37% 7.15% Fertilizer 23.92% 24.50% Power Generation and Distribution 14.13% 18.36% Commercial Banks 3.66% 22.67% Source: https://www.nccpl.com.pk/en/market-information/fipi-lipi/fipi-normal-daily

FOREIGN PORTFOLIO INVESTMENT TREND

Today (653) (430) 5 days average (456) 14 days average Millions

Source: https://www.nccpl.com.pk/en/market-information/fipi-lipi/fipi-normal-daily & Calculations of Kifayah Investment Management Limited

MATERIAL INFORMATION Based on the relaxation granted by the Government of Sindh on 10 May 2020, the management of the company has decided to gradually resume its operations from 12 May Amreli Steels Limited 2020 with expectation of attaining desired level of production by 18 May 2020 strictly observing the SOPs and instructions for workplace issued by the provincial government intended to avert the pandemic spread. Consequent to the approval of Competition Commission of Pakistan, the company has Fauji Cement Company Limited formally entered into Resource Sharing Agreement with Askarai Cement Limited (ACL).

The Securities and Commission of Pakistan has approved extension in time for the holding Al-Ghazi Tractors Limited of Annual General Meeting for the year ended December 31, 2019 up to June 15, 2020.

BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited, has successfully concluded its non-exclusive license agreement with Gilead Sciences Inc. for the manufacture and sale of Remdesivir (a drug granted emergency use authorization by US FDA to treat hospitalized patients with severe COVID-19 disease) under Gilead's Global Ferozsons Laboratories Limited Patients Solution Program serving the developing world. Under the licensing agreement, the Company has a right to receive a technology transfer of the Gilead manufacturing process for Remedisivir to enable it to scale up production more quickly.

Disclosure of interest by Non-Executive Director, bought 10,000 shares at an average Limited price of Rs. 720.10 each on April 12, 2020. Source: https://dps.psx.com.pk/announcements/companies CONSOLIDATED (where applicable) RESULTS and EPS (Qtr.) EPS DPS Growth over same Quarter ANNOUNCEMENTS Rs. Rs. Rs. EPS Gross Revenue Foods Limited 129.83 130.0 48.37% 17.20% Mirpurkhas Sugar Mills Limited -15.89 6 Month (12.09) NIL -1600.80% 119.21% Limited 1.35 NIL 28.37% 25.42% Source: https://dps.psx.com.pk/announcements/companies

UPCOMING BOOK CLOSURES DPS % Ex-Dividend Date

Glaxosmithkline Pakistan Ltd 60% (F) 13-05-2020 25%(i) 13-05-2020 MCB Bank Limited 50% (i) 13-05-2020 Cyan Limited 10% (F) 13-05-2020 120% (F) 13-05-2020 Source: https://dps.psx.com.pk/Downloads/quote_202013may.pdf EXCHANGE RATE Change Closing PKR / USD 0.31% 160.95 Source:http://www.sbp.org.pk/ecodata/rates/m2m/2020/May/13-May-20.pdf

KIFAYAH INVESTMENT MANAGEMENT LIMITED

Office No. 402, 4th Floor, Plot No. 6-C, [email protected] 021-38922660 Khayaban-e-Rizwan, Phase VII, DHA www.kifayah.com